SCHEMBL6597221

SCHEMBL6597221

CCOCCOCCOc1ccc(CC(=O)O)cc1

nearest known ligand 0.65

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PLA2G4B P0C869 1/20 0.57
LTB4R Q15722 4/20 0.52
LTB4R2 Q9NPC1 4/20 0.52
LMNA P02545 2/20 0.51
ALDH1A1 P00352 1/20 0.51
THRA P10827 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
ACACB O00763 1/20 0.49
PPARD Q03181 1/20 0.49
RARB P10826 1/20 0.49
KDM4E B2RXH2 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
PDE4A P27815 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HIF1A Q16665 1/20 0.49
HDAC10 Q969S8 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11683055 0.86 PLA2G4B (0.61) PLA2G4BLTB4RLTB4R2LMNAALDH1A1
SCHEMBL7150227 0.85 ACACB (0.53) PLA2G4BLMNAALDH1A1THRAL3MBTL1
SCHEMBL1443020 0.83 LMNA (0.70) PLA2G4BLTB4RLTB4R2LMNAALDH1A1
SCHEMBL1285778 0.83 PLA2G4B (0.77) PLA2G4BLMNAALDH1A1THRAL3MBTL1
SCHEMBL503308 0.83 PLA2G4B (0.58) PLA2G4BLTB4RLTB4R2ALDH1A1L3MBTL1
SCHEMBL29926191 0.83 LMNA (0.74) LMNATHRAL3MBTL1PPARD
SCHEMBL9787773 0.83 TBXAS1 (0.57) ALDH1A1THRAACACBKDM4ECYP1A2
SCHEMBL9787733 0.82 KMT2A (0.64) LTB4RLTB4R2ALDH1A1L3MBTL1PPARD
Hydrochloric Acid SCHEMBL2525330 0.81 LMNA (0.68) PLA2G4BLTB4RLTB4R2LMNAALDH1A1
SCHEMBL3331503 0.81 PLA2G4B (0.57) PLA2G4BLTB4RLTB4R2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1280802-B1 INDAZOLES SUBSTITUTED WITH 1,1-DIOXOISOTHIAZOLIDINE USEFUL AS INHIBITORS OF CELL PROLIFERATION LG LIFE SCIENCES LTD (KR) 2004-05-06 EP disclosed
US-6620831-B2 Cyclin dependent kinase inhibitors; anticarcinogenic and antiinflammatory agents; restenosis, angiogenesis LG LIFE SCIENCES LTD. (KR) 2003-09-16 US disclosed
US-20030149034-A1 INDAZOLES SUBSTITUTED WITH1,1-DIOXOISOTHIAZOLIDINE USEFUL AS INHIBITORS OF CELL PROLIFERATION LG LIFE SCIENCES LTD. (KR) 2003-08-07 US disclosed
EP-1280802-A4 INDAZOLES SUBSTITUTED WITH 1,1-DIOXOISOTHIAZOLIDINE USEFUL AS INHIBITORS OF CELL PROLIFERATION LG LIFE SCIENCES LTD (KR) 2003-06-11 EP disclosed
EP-1280802-A1 INDAZOLES SUBSTITUTED WITH 1,1-DIOXOISOTHIAZOLIDINE USEFUL AS INHIBITORS OF CELL PROLIFERATION LG Life Sciences Ltd. (KR) 2003-02-05 EP disclosed
WO-2001085726-A1 INDAZOLES SUBSTITUTED WITH 1,1-DIOXOISOTHIAZOLIDINE USEFUL AS INHIBITORS OF CELL PROLIFERATION LG LIFE SCIENCES LTD. (KR) 2001-11-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030149034-A1 INDAZOLES SUBSTITUTED WITH1,1-DIOXOISOTHIAZOLIDINE USEFUL AS INHIBITORS OF CELL PROLIFERATION CCNA1, CCNI, CCNT1 PLA2G4B 3940/4885LTB4R 1433/4885LTB4R2 1857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.